TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/20 20:07 | 6/23/20 | PRNB | Principia Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Babler Martin | CA | DO | P,CEO | M.d | 45 | 3.00 | 0 | 15 | 35 | 58 | D | ||||||||||||||
6/25/20 20:07 | 6/23/20 | PRNB | Principia Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Babler Martin | CA | DO | P,CEO | S.d | -928 | 61.86 | 0 | -15 | -20 | 58 | D | ||||||||||||||
3/5/20 17:21 | 3/3/20 | PRNB | Principia Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Babler Martin | CA | DO | P,CEO | S.d | -952 | 63.47 | 0 | -15 | -28 | 39 | M | ||||||||||||||
12/19/19 21:06 | 12/17/19 | PRNB | Principia Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Babler Martin | CA | DO | P,CEO | S.m | -1,565 | 53.07 | 0 | -30 | -62 | 18 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |